Key result
Alpha 1-adrenergic receptor stimulation with phenylephrine significantly decreased the maximum shortening velocity of skinned single ventricular myocytes from rats compared to control.
Why the study?
Does alpha 1-adrenergic receptor stimulation decrease maximum shortening velocity in skinned single ventricular myocytes from rats?
Does alpha 1-adrenergic receptor stimulation decrease maximum shortening velocity in skinned single ventricular myocytes from rats?
Answers are grounded in this paper and cite their sources.
Alpha 1-adrenergic receptor stimulation decreases maximum shortening velocity in rat ventricular myocytes, suggesting inhibition of cross-bridge cycling rate at the myofilament level.
alpha 1-Adrenergic agonists have negative inotropic effects on mammalian myocardium under some conditions, and biochemical experiments measuring the Ca(2+)-activated actomyosin ATPase activity of myofibrillar preparations suggest that this may result from a decrease in cross-bridge cycling rate caused by phosphorylation of myofilament proteins. Experiments with intact ventricular preparations, however, have failed to demonstrate a mechanical manifestation of a decrease in cycling rate. The present study examined the effect of alpha 1-adrenergic receptor stimulation on maximum shortening velocity in skinned single ventricular myocytes from rats. Enzymatically isolated myocytes were incubated with the beta-receptor antagonist propranolol in the presence or absence of the alpha 1-adrenergic receptor agonist phenylephrine and were then rapidly skinned to preserve the phosphorylation state of myofilament proteins. The velocity of unloaded shortening (Vo) was determined by use of the slack-test method and compared between skinned control and phenylephrine-treated cells. The relationship between isometric tension and [Ca2+] was also assessed for each myocyte. Vo was significantly lower in the alpha 1-adrenergic receptor agonist-treated cells than in the control cells, but there was no effect on Ca2+ sensitivity of isometric tension. In addition, the myosin heavy chain isoform composition accounted for a significant amount of the variation in Vo within the treatment groups. On the basis of these and previous results we propose that alpha 1-adrenergic receptor stimulation inhibits cross-bridge cycling rate at the level of myofilament proteins by a mechanism that may involve phosphorylation of troponin I by protein kinase C.
No takes yet. Share an insight, caveat, or question.
Strang et al. (1995) studied this question. alpha 1-adrenergic receptor agonist phenylephrine vs. control was evaluated on velocity of unloaded shortening (Vo). Alpha 1-adrenergic receptor stimulation with phenylephrine significantly decreased the maximum shortening velocity of skinned single ventricular myocytes from rats compared to control.
Synapse has enriched 10 related papers. Consider them for comparative context: